GLP-1 drugs help protect against sleep apnea, study saysGLP-1 drugs help protect against sleep apnea, study says
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With DiabetesGLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2… (MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the Read More
Breast cancer protein discovery could restore hormone therapy responseBreast cancer protein discovery could restore hormone therapy response
Know someone who’s been diagnosed with breast cancer? There’s a good chance that person has received hormone therapy. Estrogen receptor-positive (ER+) breast cancers account for about 75% of cases. Hormone therapy is one of the most common and effective treatments. However, it’s far from a cure.
OTC CGM at Walmart; California’s Own Insulin; Ozempic’s Price Negotiations UnderwayOTC CGM at Walmart; California’s Own Insulin; Ozempic’s Price Negotiations Underway
(MedPage Today) — Walmart will be the first physical U.S. retailer to carry Abbott’s over-the-counter (OTC) continuous glucose monitor (CGM). (Axios) Very few U.S. adults have heard of cardiovascular-kidney-metabolic syndrome despite almost 90… (MedPage Today) — Walmart will be the first physical U.S. retailer to carry Abbott’s over-the-counter (OTC) continuous glucose monitor (CGM). (Axios) Read More
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrenceAI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether this type of tumor will reappear remains one of the key challenges in oncology.
Clinical Highlights From ESC 2025—GLP-1 Drugs in Heart Failure and MoreClinical Highlights From ESC 2025—GLP-1 Drugs in Heart Failure and More
This Medical News article is an interview with Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, about clinical highlights from the European Society of Cardiology Congress held recently in Madrid. This Medical News article is an interview with Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Read More
GLP-1 Drugs May Manage Weight Recurrence After Bariatric SurgeryGLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery
Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common among those with less postsurgical weight loss. Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common Read More
Obesity-related cancer rising among both younger and older adults worldwide, study findsObesity-related cancer rising among both younger and older adults worldwide, study finds
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSAMortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest Physicians, held from Oct. 19 to 22 in Chicago. Patients Read More
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular ProtectionFDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
(MedPage Today) — The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they’ve had such an event already, Novo Nordisk announced. Semaglutide 7… (MedPage Today) — The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients Read More